Clinical Trials Browser

Phase 1 × asciminib × Other solid neoplasm × Clear all

NCT03292783 2021-07-07

This is a Study to Evaluate the Safety and Tolerability of the Study Drug ABL001, and to Determine the Maximum Tolerated Dose and/or Recommended Phase 2 Study Dose of ABL001

Phase 1 Completed

Other solid neoplasm

Advanced Solid Tumors